BBI-2000

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBBI-2000
Drug Alias NameBBI-2000BBI-2111
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCell movement inhibitorsImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsDermatitis, Allergic ContactDermatitis, Contact
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSyngenta Crop Protection AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDermatitis, Allergic ContactDermatitis, Contact

Other Information

ATC CodeN/A
Related LinksN/A